INDV

Indivior Pharmaceuticals, Inc. $35.25 as of 2026-10-29
Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
-0.4%
Next 1 week
+1.1%
Next 1 month
+1.5%
Seasonality
Mildly positive window
Next 30 days (to Nov 29): +2.2% median, 55% of the last 11 years finished up.
20-year seasonality chart →
Mean reversion
Deeply overbought — RSI(2) at 91
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is -0.80%/day.
Mean-reversion stats →
1-month breakdown — Market · β 0.54 +1.6% · Seasonal tilt (11y) -0.1%
$93M/day volume 37% volatility +42% 1-year -18% from ATH
52-week range · 58% of the way up · -18% from the high
$24.74$42.81

Earnings Full history →

Next report 2026-10-29 (Thursday, before open, in 0 days) · EPS est. 1.13.

1-day std dev
11.5%
Finished up
65%
Biggest pop
+21.7%
Biggest drop
-17.6%

Standard deviation of the close-to-close move over the last 17 reports. History, not a forecast.

ReportedEst.Actual SurpriseGap Day 1Day 5
2026-08-03 beat 0.92 1.15 +24.8% +0.7% -6.6% -3.8%
2026-04-30 beat 0.66 0.96 +45.5% +5.3% +7.7% +16.0%
2026-02-26 beat 0.67 0.82 +21.7% +2.6% +0.2% -4.7%
2025-10-30 beat 0.41 0.72 +74.9% +18.9% +15.4% +26.3%
2025-07-31 beat 0.25 0.51 +104.0% +19.9% +16.1% +26.7%
2025-04-24 beat 0.23 0.41 +75.7% +10.1% +13.9% +22.2%
2025-02-20 beat 0.26 0.32 +22.6% -17.7% -17.6% -18.6%
2024-10-24 beat 0.41 0.54 +32.8% +6.5% +2.5% +5.3%
2024-07-25 beat 0.40 0.44 +9.1% +16.5% +20.3% +25.2%
2024-04-25 miss 0.42 0.37 -10.8% -4.6% -8.3% -4.7%
2024-02-22 beat 0.28 0.43 +53.6% +14.6% +21.7% +22.5%
2023-11-09 beat 0.30 0.34 +13.3% -6.7% -5.5% -15.6%
2023-07-27 beat 0.22 0.39 +77.3% -1.6% -3.6% -8.1%
2017-02-22 0.35 0.35 — +0.0% +0.0% -4.4%
2016-11-02 beat 0.27 0.50 +85.2% +4.7% +13.8% +17.7%
2016-07-29 beat 0.34 0.55 +64.2% +9.7% +9.7% +10.9%
2016-02-18 beat 0.20 0.35 +75.0% +18.2% +16.7% +10.3%

Not investment advice.